Association of Symptoms After COVID-19 Vaccination With Anti-SARS-CoV-2 Antibody Response in the Framingham Heart Study.

Hermann, Emilia A; Lee, Benjamin; Balte, Pallavi P; Xanthakis, Vanessa; Kirkpatrick, Beth D; Cushman, Mary; Oelsner, Elizabeth

Hermann, Emilia A; Lee, Benjamin; Balte, Pallavi P; Xanthakis, Vanessa; Kirkpatrick, Beth D; Cushman, Mary; Oelsner, Elizabeth.

Affiliation

Hermann EA; Division of General Medicine, Department of Medicine, Columbia University, New York, New York.
Lee B; Department of Pediatrics, Larner College of Medicine at the University of Vermont, Burlington.
Balte PP; Division of General Medicine, Department of Medicine, Columbia University, New York, New York.
Xanthakis V; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Kirkpatrick BD; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Cushman M; Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington.
Oelsner E; Department of Microbiology and Molecular Genetics, Larner College of Medicine, University of Vermont, Burlington.

JAMA Netw Open ; 5(10): e2237908, 2022 10 03.

Article in En | MEDLINE | ID: mdl-36269359

This cohort study examines the association of self-reported postvaccination symptoms with antiSARS-CoV-2 antibody response among Framingham Heart Study participants contributing to the Collaborative Cohort of Cohorts for COVID-19 Research study.

Subject(s)

COVID-19 Vaccines; COVID-19; Humans; COVID-19/prevention & control; Antibody Formation; Antibodies, Viral; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Netw Open Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google